GO
Loading...

Valeant Pharmaceuticals International Inc

More

  • NEW YORK/ BOSTON, Aug 20- A few months ago, an innovative partnership between Valeant Pharmaceuticals and billionaire investor William Ackman to buy Botox maker Allergan Inc looked like a blueprint for success.

  • Aug 19- Botox maker Allergan Inc has approached Salix Pharmaceuticals Ltd and at least one other company about a potential takeover in a bid to avert the $53 billion hostile takeover from Valeant Pharmaceuticals International Inc, the Wall Street Journal said. Allergan and Salix declined to comment on the matter.

  • Allergan names Hindman chief financial officer Monday, 18 Aug 2014 | 1:12 PM ET

    IRVINE, Calif.— Botox maker Allergan, which is fighting a hostile takeover bid from Valeant Pharmaceuticals, has named longtime executive Jim Hindman its new chief financial officer. Allergan Chairman and CEO David E.I. Pyott said in a statement from the company that Edwards told him back in February that he was thinking about stepping down later in the year.

  • Aug 14- Pershing Square Capital Management LP, the hedge fund firm run by William Ackman, has sued the U.S. government, claiming that its stripping of Fannie Mae's and Freddie Mac's profit illegally short changes investors in the mortgage companies' common stock.

  • Aug 14- U.S. securities regulators are looking at the hostile takeover bid made by billionaire investor William Ackman and Valeant Pharmaceuticals for Botox maker Allergan Inc, a person familiar with the matter said on Thursday.

  • Aug 14- A hostile takeover bid by billionaire investor William Ackman and Valeant Pharmaceuticals International Inc to acquire Allergan Inc is being investigated by federal regulators for possible violations of securities laws, the Wall Street Journal reported, citing people familiar with the matter.

  • *Equities have come under pressure because of the problems between Russia and Ukraine, with the S&P 500 at one point down about 4 percent from a record closing high in late July. *The gain implied by futures came despite ongoing concerns about the region, with Ukraine reporting that Russia had massed 45,000 troops on its border.

  • Aug 8- The federal judge in California overseeing Allergan Inc's insider trading lawsuit against Valeant Pharmaceuticals and activist investor William Ackman has set an Aug. 20 hearing date to decide on a fast-track schedule for the case, according to court documents.

  • ZURICH, Aug 7- Nestle, the world's biggest food group, announced an 8 billion Swiss franc share buyback and stood by its full-year sales forecast on Thursday, after revenue growth in emerging markets picked up in the second quarter.

  • Aug 6- Institutional Shareholder Services is backing activist investor Bill Ackman's call for a special meeting of Allergan Inc investors that could topple the company's board and increase the chances of a takeover by Valeant Pharmaceuticals International.

  • Aug 6- Institutional Shareholder Services is backing activist investor Bill Ackman's call for a special meeting of Allergan Inc investors that could topple the Botox-maker's board and increase the chances of a takeover by Valeant Pharmaceuticals International.

  • Bill Ackman

    A lawsuit by Allergan says the unusual arrangement by Valeant Pharmaceuticals and activist investor Bill Ackman amounts to insider trading.

  • Ackman's Pershing Square Holdings fund up 27% Monday, 4 Aug 2014 | 4:15 PM ET
    Bill Ackman

    Ackman's Pershing Square Holdings fund has risen 27.2 percent after extending its gains modestly while many hedge fund managers suffered losses.

  • BOSTON, Aug 4- Billionaire investor William Ackman's Pershing Square Holdings has risen 27.2 percent this year, according to an investor in the fund, after extending its gains modestly last month when many hedge fund managers suffered losses.

  • Aug 1- Botox maker Allergan Inc on Friday accused rival Valeant Pharmaceuticals International and billionaire investor William Ackman of violating securities laws by using insider information as they prepared a takeover bid for the drug company.

  • A live market monitor is viewed on the floor of the New York Stock Exchange (NYSE).

    Some of Friday's midday movers:

  • Allergan takes Ackman, Valeant battle to court Friday, 1 Aug 2014 | 11:35 AM ET
    Bill Ackman and Michael Pearson

    Allergan sued Valeant Pharmaceuticals and Pershing Square Capital, alleging both acted inappropriately in their hostile $53 billion bid.

  • Midday movers: Exxon Mobil, Kellogg, Sony & More Thursday, 31 Jul 2014 | 2:14 PM ET

    Some of Thursday's midday movers:

  • July 31- Canada's Valeant Pharmaceuticals International Inc, embroiled in a bitter battle to take over Botox-maker Allergan Inc, on Thursday cut its 2014 and 2015 profit forecasts, sending shares 10 percent lower.

  • UPDATE 1-Allergan-bidder Valeant cuts 2014 outlook Thursday, 31 Jul 2014 | 7:54 AM ET

    July 31- Canada's Valeant Pharmaceuticals International Inc, embroiled in a bitter battle to take over Botox-maker Allergan Inc, cut its full-year profit and revenue forecasts to reflect the sale of its rights to several skincare products.